# BiovelocITA

> BiovelocITA is a VC fund in Milano backing Therapeutics and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Milano, Italy
- Total investments: 2
- Last investment: Apr 2023
- Lead investor: 50%
- Last updated: Sep 2026
- Website: http://www.biovelocita.com/

BiovelocITA is a VC fund in Milano focused on Therapeutics and Biotechnology. BiovelocITA brings together best-in-class scientists, entrepreneurs and investors to foster the development of pioneering companies. BiovelocITA is co-founded and promoted by Sofinnova Partners, a historical player on the Italian biotech market. Active in Italy for more than fifteen years, Sofinnova Partners is in a privileged position to helpItaly grow into one of Europe’s strongest biotech market.

## Contacts

5 contacts available for BiovelocITA. Shizune tracks 2 team members at BiovelocITA. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/biovelocita?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gabriella Camboni | CEO | 1 | — |
| Silvano Spinelli | Chairman | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alia Therapeutics | Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases. | $4.8M | Seed | Apr 17, 2023 | https://www.aliatherapeutics.com/ |
| Alia Therapeutics | Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases. | $1.5M | Seed | Apr 08, 2019 | https://www.aliatherapeutics.com/ |

2 of 2 investments shown.

## Co-investors
- [Sofinnova Partners](https://shizune.co/investors/profile/sofinnova-partners) — VC Fund, 2 deals together
- [Indaco Venture Partners](https://shizune.co/investors/profile/indaco-venture-partners) — VC Fund, 1 deal together
- [Trentino Invest Srl](https://shizune.co/investors/profile/trentino-invest-srl) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BiovelocITA invest in?

BiovelocITA invests primarily in Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BiovelocITA?

Public channels for BiovelocITA include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BiovelocITA?

The team at BiovelocITA includes Gabriella Camboni (CEO) and Silvano Spinelli (Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co